Pavel Mirovsky
2014
In 2014, Pavel Mirovsky earned a total compensation of $10.9M as President and General Manager, Europe at Valeant Pharmaceuticals International, a 1,226% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $330,000 |
|---|---|
| Option Awards | $3,816,896 |
| Salary | $499,274 |
| Stock Awards | $6,254,330 |
| Other | $23,272 |
| Total | $10,923,772 |
Mirovsky received $6.3M in stock awards, accounting for 57% of the total pay in 2014.
Mirovsky also received $330K in non-equity incentive plan, $3.8M in option awards, $499.3K in salary and $23.3K in other compensation.
Rankings
In 2014, Pavel Mirovsky's compensation ranked 444th out of 13,032 executives tracked by ExecPay. In other words, Mirovsky earned more than 96.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 444 out of 13,032 | 97th |
Division Manufacturing | 153 out of 4,966 | 97th |
Major group Chemicals And Allied Products | 48 out of 1,686 | 97th |
Industry group Drugs | 38 out of 1,365 | 97th |
Industry Pharmaceutical Preparations | 36 out of 1,043 | 97th |
Source: SEC filing on April 9, 2015.
Mirovsky's colleagues
We found six more compensation records of executives who worked with Pavel Mirovsky at Valeant Pharmaceuticals International in 2014.
2014
Ari Kellen
Valeant Pharmaceuticals International
Group Chairman
2014
Howard Schiller
Valeant Pharmaceuticals International
Chief Financial Officer
2014
Robert Chai-Onn
Valeant Pharmaceuticals International
Chief Legal Officer
2014
J Pearson
Valeant Pharmaceuticals International
Chief Executive Officer
2014
Debora Jorn
Valeant Pharmaceuticals International
Group Chairman
2014
Brian Stolz
Valeant Pharmaceuticals International